Akston Biosciences And Biolexis Collaborate To Launch A Room Temperature Stable 2Nd Generation Covid-19 Vaccine
17/03/2022 14:29
Strides Pharma Science Ltd SRID.NS :
* STRIDES PHARMA SCIENCE LTD - AKSTON BIOSCIENCES AND
BIOLEXIS
COLLABORATE TO LAUNCH A ROOM TEMPERATURE STABLE 2ND GENERATION
COVID-19 VACCINE
Source text for Eikon: ID:nBSE8jN8jh
Further company coverage: SRID.NS
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees